1. Adding Hydrochlorothiazide to Olmesartan/Amlodipine Increases Efficacy in Patients With Inadequate Blood Pressure Control on Dual‐Combination Therapy. Issue 1 (14th July 2015) Authors: Rump, Lars C.; Ammentorp, Bettina; Laeis, Petra; Scholze, Jürgen Journal: Journal of clinical hypertension Issue: Volume 18:Issue 1(2016:Jan.) Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Design and rationale of the Edoxaban Treatment in routiNe clinical prActice for patients with Atrial Fibrillation in Europe (ETNA-AF-Europe) study. Issue 2 (February 2019) Authors: De Caterina, Raffaele; Kelly, Peter; Monteiro, Pedro; Deharo, Jean Claude; de Asmundis, Carlo; López-de-Sá, Esteban; Weiss, Thomas W.; Waltenberger, Johannes; Steffel, Jan; de Groot, Joris R.; Levy, Pierre; Bakhai, Ameet; Zierhut, Wolfgang; Laeis, Petra; Reimitz, Paul-Egbert; Kirchhof, Paulus Journal: Journal of cardiovascular medicine Issue: Volume 20:Issue 2(2019:Feb.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical care. Issue 1 (26th July 2022) Authors: Kirchhof, Paulus; Pecen, Ladislav; Bakhai, Ameet; de Asmundis, Carlo; de Groot, Joris R; Deharo, Jean Claude; Kelly, Peter; Levy, Pierre; Lopez-de-Sa, Esteban; Monteiro, Pedro; Steffel, Jan; Waltenberger, Johannes; Weiss, Thomas W; Laeis, Petra; Manu, Marius Constantin; Souza, José; De Caterina, ... Journal: European heart journal Issue: Volume 9:Issue 1(2023) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study. Issue Volume 7:Issue FI1(2021) (13th August 2020) Authors: de Groot, Joris R; Weiss, Thomas W; Kelly, Peter; Monteiro, Pedro; Deharo, Jean Claude; de Asmundis, Carlo; López-de-Sá, Esteban; Waltenberger, Johannes; Steffel, Jan; Levy, Pierre; Bakhai, Ameet; Zierhut, Wolfgang; Laeis, Petra; Manu, Marius Constantin; Reimitz, Paul-Egbert; De Caterina, Raffael... Journal: European heart journal Issue: Volume 7:Issue FI1(2021) Page Start: f30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial. (29th August 2020) Authors: Vranckx, Pascal; Valgimigli, Marco; Eckardt, Lars; Lewalter, Thorsten; Unikas, Ramunas; Marin, Francisco; Schiele, François; Laeis, Petra; Reimitz, Paul-Egbert; Smolnik, Rüdiger; Zierhut, Wolfgang; Tijssen, Jan; Goette, Andreas Journal: European heart journal Issue: Volume 41:Number 47(2020) Page Start: 4497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial. Issue 10206 (12th October 2019) Authors: Vranckx, Pascal; Valgimigli, Marco; Eckardt, Lars; Tijssen, Jan; Lewalter, Thorsten; Gargiulo, Giuseppe; Batushkin, Valerii; Campo, Gianluca; Lysak, Zoreslava; Vakaliuk, Igor; Milewski, Krzysztof; Laeis, Petra; Reimitz, Paul-Egbert; Smolnik, Rüdiger; Zierhut, Wolfgang; Goette, Andreas Journal: Lancet Issue: Volume 394:Issue 10206(2019) Page Start: 1335 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and Tolerability of Triple‐Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: A Subgroup Analysis of Patients Stratified by Hypertension Severity, Age, Sex, and Obesity. Issue 10 (20th September 2014) Authors: Kreutz, Reinhold; Ammentorp, Bettina; Laeis, Petra; de la Sierra, Alejandro Journal: Journal of clinical hypertension Issue: Volume 16:Issue 10(2014:Oct.) Page Start: 729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months. Issue 196 (December 2020) Authors: Agnelli, Giancarlo; Hoffmann, Ulrich; Hainaut, Philippe; Gaine, Sean; Ay, Cihan; Coppens, Michiel; Schindewolf, Marc; Jimenez, David; Brüggenjürgen, Bernd; Levy, Pierre; Laeis, Petra; Fronk, Eva-Maria; Zierhut, Wolfgang; Malzer, Thomas; Manu, Marius Constantin; Reimitz, Paul-Egbert; Bramlage, Pet... Journal: Thrombosis research Issue: Issue 196(2020) Page Start: 297 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Oral anticoagulant use in octogenarian European patients with atrial fibrillation: A subanalysis of PREFER in AF. (1st April 2017) Authors: Hanon, Olivier; Vidal, Jean-Sébastien; Le Heuzey, Jean-Yves; Kirchhof, Paulus; De Caterina, Raffaele; Schmitt, Josef; Laeis, Petra; Mannucci, Pier Mannuccio; Marcucci, Maura Journal: International journal of cardiology Issue: Volume 232(2017) Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Routine clinical practice in the periprocedural management of edoxaban therapy is associated with low risk of bleeding and thromboembolic complications: The prospective, observational, and multinational EMIT‐AF/VTE study. Issue 7 (14th May 2020) Authors: Colonna, Paolo; von Heymann, Christian; Santamaria, Amparo; Saxena, Manish; Vanassche, Thomas; Wolpert, Diana; Laeis, Petra; Wilkins, Robert; Chen, Cathy; Unverdorben, Martin Journal: Clinical cardiology Issue: Volume 43:Issue 7(2020) Page Start: 769 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗